SG Cowen & Co. 25th Annual Healthcare Conference to Webcast Millennium Presentation
3/10/2005 4:01:08 PM
Cambridge, Mass., March 10, 2005 /PRNewswire-FirstCall via COMTEX/ -- Millennium Pharmaceuticals, Inc. (MLNM) today announced that its presentation at the SG Cowen & Co. 25th Annual Healthcare Conference will be webcast live and may be accessed by visiting the Investors section of the Company's website, millennium.com.
Millennium management will provide an overview of the Company, further details on the Company's recently achieved milestones that will result in payments of approximately $40 million and upcoming corporate events. The presentation will be delivered at 8:50 a.m. EST on Thursday, March 17, 2005 from the Boston Marriott Copley Place. The presentation will be archived for 30 days.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, co-promotes INTEGRILIN(R) (eptifibatide) Injection, a market-leading cardiovascular product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in three therapeutic areas: oncology, cardiovascular, and inflammation. By applying its knowledge of the human genome, its understanding of disease mechanisms, and its industrialized drug discovery platform, Millennium is seeking to develop breakthrough products.
Editors' Note: This press release is also available under the Media section of the Company's website at: millennium.com. |
